Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HOWARU Business Partners is the specialized probiotic division of IFF Health & Biosciences, providing high-quality, clinically documented probiotic solutions to the global health and wellness industry. The company offers a comprehensive portfolio of proprietary strains, including the widely recognized HOWARU brand, which targets specific health areas such as digestive health, immune support, and women's wellness. Beyond ingredient supply, HOWARU Business Partners provides technical formulation support, clinical trial data, and regulatory guidance to help customers launch finished dietary supplements. Their business model focuses on B2B partnerships, leveraging decades of microbial research inherited from Danisco and DuPont. The company maintains a strong emphasis on science, with numerous human clinical trials backing the efficacy and safety of their probiotic offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HOWARU Business Partners.